1 Introduction to Research & Analysis Reports
1.1 Acute Liver Failure Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Liver Failure Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Liver Failure Treatment Overall Market Size
2.1 Global Acute Liver Failure Treatment Market Size: 2022 VS 2029
2.2 Global Acute Liver Failure Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Liver Failure Treatment Players in Global Market
3.2 Top Global Acute Liver Failure Treatment Companies Ranked by Revenue
3.3 Global Acute Liver Failure Treatment Revenue by Companies
3.4 Top 3 and Top 5 Acute Liver Failure Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Acute Liver Failure Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Liver Failure Treatment Players in Global Market
3.6.1 List of Global Tier 1 Acute Liver Failure Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute Liver Failure Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Acute Liver Failure Treatment Market Size Markets, 2022 & 2029
4.1.2 Hepatocyte Transplantation
4.1.3 Assisted Liver Transplantation
4.1.4 Xenotransplantation
4.2 By Type – Global Acute Liver Failure Treatment Revenue & Forecasts
4.2.1 By Type – Global Acute Liver Failure Treatment Revenue, 2018-2023
4.2.2 By Type – Global Acute Liver Failure Treatment Revenue, 2024-2029
4.2.3 By Type – Global Acute Liver Failure Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Acute Liver Failure Treatment Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Liver Academic and Research Institutes
5.1.5 Forensic Laboratories
5.2 By Application – Global Acute Liver Failure Treatment Revenue & Forecasts
5.2.1 By Application – Global Acute Liver Failure Treatment Revenue, 2018-2023
5.2.2 By Application – Global Acute Liver Failure Treatment Revenue, 2024-2029
5.2.3 By Application – Global Acute Liver Failure Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Acute Liver Failure Treatment Market Size, 2022 & 2029
6.2 By Region – Global Acute Liver Failure Treatment Revenue & Forecasts
6.2.1 By Region – Global Acute Liver Failure Treatment Revenue, 2018-2023
6.2.2 By Region – Global Acute Liver Failure Treatment Revenue, 2024-2029
6.2.3 By Region – Global Acute Liver Failure Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Acute Liver Failure Treatment Revenue, 2018-2029
6.3.2 US Acute Liver Failure Treatment Market Size, 2018-2029
6.3.3 Canada Acute Liver Failure Treatment Market Size, 2018-2029
6.3.4 Mexico Acute Liver Failure Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Acute Liver Failure Treatment Revenue, 2018-2029
6.4.2 Germany Acute Liver Failure Treatment Market Size, 2018-2029
6.4.3 France Acute Liver Failure Treatment Market Size, 2018-2029
6.4.4 U.K. Acute Liver Failure Treatment Market Size, 2018-2029
6.4.5 Italy Acute Liver Failure Treatment Market Size, 2018-2029
6.4.6 Russia Acute Liver Failure Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Acute Liver Failure Treatment Market Size, 2018-2029
6.4.8 Benelux Acute Liver Failure Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Acute Liver Failure Treatment Revenue, 2018-2029
6.5.2 China Acute Liver Failure Treatment Market Size, 2018-2029
6.5.3 Japan Acute Liver Failure Treatment Market Size, 2018-2029
6.5.4 South Korea Acute Liver Failure Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Acute Liver Failure Treatment Market Size, 2018-2029
6.5.6 India Acute Liver Failure Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Acute Liver Failure Treatment Revenue, 2018-2029
6.6.2 Brazil Acute Liver Failure Treatment Market Size, 2018-2029
6.6.3 Argentina Acute Liver Failure Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Acute Liver Failure Treatment Revenue, 2018-2029
6.7.2 Turkey Acute Liver Failure Treatment Market Size, 2018-2029
6.7.3 Israel Acute Liver Failure Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Acute Liver Failure Treatment Market Size, 2018-2029
6.7.5 UAE Acute Liver Failure Treatment Market Size, 2018-2029
7 Acute Liver Failure Treatment Companies Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Acute Liver Failure Treatment Major Product Offerings
7.1.4 Novartis AG Acute Liver Failure Treatment Revenue in Global Market (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Bayer AG
7.2.1 Bayer AG Company Summary
7.2.2 Bayer AG Business Overview
7.2.3 Bayer AG Acute Liver Failure Treatment Major Product Offerings
7.2.4 Bayer AG Acute Liver Failure Treatment Revenue in Global Market (2018-2023)
7.2.5 Bayer AG Key News & Latest Developments
7.3 Cardiorentis AG
7.3.1 Cardiorentis AG Company Summary
7.3.2 Cardiorentis AG Business Overview
7.3.3 Cardiorentis AG Acute Liver Failure Treatment Major Product Offerings
7.3.4 Cardiorentis AG Acute Liver Failure Treatment Revenue in Global Market (2018-2023)
7.3.5 Cardiorentis AG Key News & Latest Developments
7.4 Cytokinetics, Inc.
7.4.1 Cytokinetics, Inc. Company Summary
7.4.2 Cytokinetics, Inc. Business Overview
7.4.3 Cytokinetics, Inc. Acute Liver Failure Treatment Major Product Offerings
7.4.4 Cytokinetics, Inc. Acute Liver Failure Treatment Revenue in Global Market (2018-2023)
7.4.5 Cytokinetics, Inc. Key News & Latest Developments
7.5 Orion Corporation
7.5.1 Orion Corporation Company Summary
7.5.2 Orion Corporation Business Overview
7.5.3 Orion Corporation Acute Liver Failure Treatment Major Product Offerings
7.5.4 Orion Corporation Acute Liver Failure Treatment Revenue in Global Market (2018-2023)
7.5.5 Orion Corporation Key News & Latest Developments
7.6 Bristol-Myers Squibb Company
7.6.1 Bristol-Myers Squibb Company Company Summary
7.6.2 Bristol-Myers Squibb Company Business Overview
7.6.3 Bristol-Myers Squibb Company Acute Liver Failure Treatment Major Product Offerings
7.6.4 Bristol-Myers Squibb Company Acute Liver Failure Treatment Revenue in Global Market (2018-2023)
7.6.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.7 PhaseBio Pharmaceuticals, InC
7.7.1 PhaseBio Pharmaceuticals, InC Company Summary
7.7.2 PhaseBio Pharmaceuticals, InC Business Overview
7.7.3 PhaseBio Pharmaceuticals, InC Acute Liver Failure Treatment Major Product Offerings
7.7.4 PhaseBio Pharmaceuticals, InC Acute Liver Failure Treatment Revenue in Global Market (2018-2023)
7.7.5 PhaseBio Pharmaceuticals, InC Key News & Latest Developments
7.8 Merck & Co
7.8.1 Merck & Co Company Summary
7.8.2 Merck & Co Business Overview
7.8.3 Merck & Co Acute Liver Failure Treatment Major Product Offerings
7.8.4 Merck & Co Acute Liver Failure Treatment Revenue in Global Market (2018-2023)
7.8.5 Merck & Co Key News & Latest Developments
7.9 CVie Therapeutics Limited
7.9.1 CVie Therapeutics Limited Company Summary
7.9.2 CVie Therapeutics Limited Business Overview
7.9.3 CVie Therapeutics Limited Acute Liver Failure Treatment Major Product Offerings
7.9.4 CVie Therapeutics Limited Acute Liver Failure Treatment Revenue in Global Market (2018-2023)
7.9.5 CVie Therapeutics Limited Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
世界の急性肝不全治療市場予測2023-2029：肝細胞移植、肝移植補助、異種移植 |
| 【英語タイトル】Acute Liver Failure Treatment Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU4944 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：62 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医療機器＆消耗品 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の急性肝不全治療市場規模と予測を収録しています。・世界の急性肝不全治療市場：売上、2018年-2023年、2024年-2029年 ・世界の急性肝不全治療市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の急性肝不全治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「肝細胞移植」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 急性肝不全治療のグローバル主要企業は、Novartis AG、 Bayer AG、 Cardiorentis AG、 Cytokinetics, Inc.、 Orion Corporation、 Bristol-Myers Squibb Company、 PhaseBio Pharmaceuticals, InC、 Merck & Co、 CVie Therapeutics Limitedなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、急性肝不全治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の急性肝不全治療市場：タイプ別、2018年-2023年、2024年-2029年 世界の急性肝不全治療市場：タイプ別市場シェア、2022年 ・肝細胞移植、肝移植補助、異種移植 世界の急性肝不全治療市場：用途別、2018年-2023年、2024年-2029年 世界の急性肝不全治療市場：用途別市場シェア、2022年 ・病院、診療所、肝臓学術研究機関、法医学研究所 世界の急性肝不全治療市場：地域・国別、2018年-2023年、2024年-2029年 世界の急性肝不全治療市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における急性肝不全治療のグローバル売上、2018年-2023年 ・主要企業における急性肝不全治療のグローバル売上シェア、2022年 ・主要企業における急性肝不全治療のグローバル販売量、2018年-2023年 ・主要企業における急性肝不全治療のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Novartis AG、 Bayer AG、 Cardiorentis AG、 Cytokinetics, Inc.、 Orion Corporation、 Bristol-Myers Squibb Company、 PhaseBio Pharmaceuticals, InC、 Merck & Co、 CVie Therapeutics Limited ************************************************************* ・調査・分析レポートの概要 急性肝不全治療市場の定義 市場セグメント 世界の急性肝不全治療市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の急性肝不全治療市場規模 世界の急性肝不全治療市場規模：2022年 VS 2029年 世界の急性肝不全治療市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの急性肝不全治療の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の急性肝不全治療製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：肝細胞移植、肝移植補助、異種移植 急性肝不全治療のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、肝臓学術研究機関、法医学研究所 急性肝不全治療の用途別グローバル売上・予測 ・地域別市場分析 地域別急性肝不全治療市場規模 2022年と2029年 地域別急性肝不全治療売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Novartis AG、 Bayer AG、 Cardiorentis AG、 Cytokinetics, Inc.、 Orion Corporation、 Bristol-Myers Squibb Company、 PhaseBio Pharmaceuticals, InC、 Merck & Co、 CVie Therapeutics Limited ... |
Acute liver failure is a rare condition. It happens when your liver suddenly begins to lose its ability to function. This often happens right after an overdose of medicine or poisoning. For acute (sudden) liver failure, treatment includes: Intravenous (IV) fluids to maintain blood pressure; Medications such as laxatives or enemas to help flush toxins (poisons) out; Blood glucose (sugar) monitoring; glucose is given to the patient if blood sugar drops.
This report aims to provide a comprehensive presentation of the global market for Acute Liver Failure Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Liver Failure Treatment. This report contains market size and forecasts of Acute Liver Failure Treatment in global, including the following market information:
Global Acute Liver Failure Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Acute Liver Failure Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Hepatocyte Transplantation Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Acute Liver Failure Treatment include Novartis AG, Bayer AG, Cardiorentis AG, Cytokinetics, Inc., Orion Corporation, Bristol-Myers Squibb Company, PhaseBio Pharmaceuticals, InC, Merck & Co and CVie Therapeutics Limited, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acute Liver Failure Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acute Liver Failure Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Acute Liver Failure Treatment Market Segment Percentages, by Type, 2022 (%)
Hepatocyte Transplantation
Assisted Liver Transplantation
Xenotransplantation
Global Acute Liver Failure Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Acute Liver Failure Treatment Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Liver Academic and Research Institutes
Forensic Laboratories
Global Acute Liver Failure Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Acute Liver Failure Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acute Liver Failure Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Acute Liver Failure Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Bayer AG
Cardiorentis AG
Cytokinetics, Inc.
Orion Corporation
Bristol-Myers Squibb Company
PhaseBio Pharmaceuticals, InC
Merck & Co
CVie Therapeutics Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Acute Liver Failure Treatment, market overview.
Chapter 2: Global Acute Liver Failure Treatment market size in revenue.
Chapter 3: Detailed analysis of Acute Liver Failure Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acute Liver Failure Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の急性肝不全治療市場予測2023-2029：肝細胞移植、肝移植補助、異種移植] (コード：MMG23JU4944)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の急性肝不全治療市場予測2023-2029：肝細胞移植、肝移植補助、異種移植]についてメールでお問い合わせ |
